Tvardi Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $20.7M | $31.6M | $51.8M | $63.7M | $13.5M | $31.7M | $18.3M | $15.1M |
| Accounts Receivable | — | $407.0K | $2.8M | $3.3M | — | — | — | — |
| Inventory | — | $900.0K | $2.8M | $2.4M | $2.6M | — | — | — |
| Total Current Assets | $31.5M | $31.7M | $116.2M | $168.9M | $173.3M | $195.1M | $165.7M | $168.1M |
| Property, Plant & Equipment | $52.0K | $84.0K | $3.3M | $426.0K | $631.0K | $840.0K | $700.0K | $880.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $322.0K | $385.0K | — | — | — | — | — | — |
| Total Assets | $32.1M | $35.2M | $125.8M | $182.2M | $247.1M | $271.2M | $233.0M | $190.8M |
| Liabilities | ||||||||
| Accounts Payable | $3.2M | $2.2M | $11.6M | $9.6M | $5.6M | $4.9M | $9.1M | $4.4M |
| Total Current Liabilities | $11.0M | $10.4M | $25.6M | $23.5M | $17.6M | $18.5M | $42.9M | $40.4M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $11.1M | $40.8M | $68.8M | $23.5M | $19.5M | $22.2M | $46.2M | $57.2M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-110.5M | $-92.2M | $-684.7M | $-566.2M | $-480.8M | $-392.3M | $-400.7M | $-294.4M |
| Total Stockholders' Equity | $20.9M | $-91.1M | $-62.1M | $158.8M | $227.5M | $249.0M | $186.7M | $133.6M |